{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:56:01Z","timestamp":1790016961650,"version":"4.0.1"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejpb.2025.114909","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T16:26:54Z","timestamp":1761668814000},"page":"114909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Optimization of intranasal trifluoperazine\/SPION-leciplex thermosensitive organogel for depression therapy: Pharmacodynamic and pharmacokinetic comparison of magnet placement effects on brain versus nose"],"prefix":"10.1016","volume":"217","author":[{"given":"Soha","family":"Elsalhy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2082-2063","authenticated-orcid":false,"given":"Hanan","family":"Refai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina A.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrine El","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha K.A.","family":"Khalifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.ejpb.2025.114909_b0005","doi-asserted-by":"crossref","first-page":"B659","DOI":"10.1149\/2.1101613jes","article-title":"Hematite nanoparticles\/ionic liquid crystal\/graphene\u2013based nanocomposite electrochemical sensor for sensitive determination of antipsychotic drug","volume":"163","author":"Atta","year":"2016","journal-title":"J. Electrochem. Soc."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114909_b0010","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0005-2736(98)00090-X","article-title":"Contribution of trifluoperazine\/lipid ratio and drug ionization to hemolysis","volume":"1373","author":"Malheiros","year":"1998","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Biomembr."},{"issue":"13","key":"10.1016\/j.ejpb.2025.114909_b0015","first-page":"299","article-title":"Buccoadhesive tablets of triflouperazine: formulation, evaluation and effect of formulation parameters","volume":"8","author":"Alaayedi","year":"2017","journal-title":"Karbala J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.ejpb.2025.114909_b0020","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.5958\/0974-360X.2019.00856.4","article-title":"Formulation and evaluation of trifluoperazine HCl as rectal suppositories by using different types of surfactants in Cocoa butter","volume":"12","author":"Dakhil","year":"2019","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.ejpb.2025.114909_b0025","unstructured":"N.K. Maraie, Formulation and evaluation of trifluoperazine hydrochloride orodispersible tablets. 2013."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114909_b0030","first-page":"166","article-title":"Formulation and in-vitro evaluation of trifluoperazine hydrochloride bi-layer floating tablet","volume":"2","author":"Gahiwade","year":"2012","journal-title":"Int. J. Pharm. Biol. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114909_b0035","first-page":"70","article-title":"Trifluoperazine-loaded leciplexes as potential nasal delivery systems for treatment of depression","volume":"2","author":"Refai","year":"2022","journal-title":"Azhar Int. J. Pharm. Med. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114909_b0040","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/pharmaceutics11020064","article-title":"Formulation strategies to improve nose-to-brain delivery of donepezil","volume":"11","author":"Espinoza","year":"2019","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.ejpb.2025.114909_b0045","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/02652048.2020.1826590","article-title":"Novel lipid\u2013polymer hybrid nanoparticles incorporated in thermosensitive in situ gel for intranasal delivery of terbutaline sulphate","volume":"37","author":"Mohamed","year":"2020","journal-title":"J. Microencapsul."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114909_b0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/pharmaceutics12010025","article-title":"Spironolactone-loaded leciplexes as potential topical delivery systems for female acne: In vitro appraisal and ex vivo skin permeability studies","volume":"12","author":"Salama","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114909_b0055","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.5c00297","article-title":"Challenges and Opportunities for Incorporating physiological information into pharmacokinetic models of intranasal drug delivery to the brain: a review of the current status and future trajectories","author":"Rezaee","year":"2025","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114909_b0060","doi-asserted-by":"crossref","first-page":"94","DOI":"10.22270\/ajprd.v9i3.950","article-title":"Pharmaceutical considerations of nasal in-situ gel as a drug delivery system","volume":"9","author":"Khatri","year":"2021","journal-title":"Asian J. Pharm. Res. Dev."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114909_b0065","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3390\/pharmaceutics15030830","article-title":"Polymeric gel systems cytotoxicity and drug release as key features for their effective application in various fields of addressed pharmaceuticals delivery","volume":"15","author":"Smagina","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114909_b0070","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7840161","article-title":"Perspective of Fe3O4 nanoparticles role in biomedical applications","author":"Ghazanfari","year":"2016","journal-title":"Biochem. Res. Int."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114909_b0075","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/ma12040617","article-title":"Superparamagnetic iron oxide nanoparticles\u2014Current and prospective medical applications","volume":"12","author":"Duli\u0144ska-Litewka","year":"2019","journal-title":"Materials"},{"issue":"8","key":"10.1016\/j.ejpb.2025.114909_b0080","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3390\/pharmaceutics13081157","article-title":"Advantages and disadvantages of using magnetic nanoparticles for the treatment of complicated ocular disorders","volume":"13","author":"Schneider-Futschik","year":"2021","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.ejpb.2025.114909_b0085","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.xphs.2018.04.007","article-title":"Superparamagnetic iron oxide\u2013loaded lipid nanocarriers incorporated in thermosensitive in situ gel for magnetic brain targeting of clonazepam","volume":"107","author":"Abbas","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114909_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121244","article-title":"Superparamagnetic iron oxide loaded chitosan coated bilosomes for magnetic nose to brain targeting of resveratrol","author":"Abbas","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114909_b0095","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.2147\/IJN.S91631","article-title":"Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration","volume":"10","author":"Abdelbary","year":"2015","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114909_b0100","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s13369-011-0058-4","article-title":"An indirect atomic absorption spectrophotometric determination of trifluoperazine hydrochloride in pharmaceuticals","volume":"36","author":"Waleed","year":"2011","journal-title":"Arab. J. Sci. Eng."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114909_b0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.nano.2009.06.002","article-title":"Preparation of chitosan nanoparticles containing Naja naja oxiana snake venom","volume":"6","author":"Mohammadpourdounighi","year":"2010","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114909_b0110","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/02652048.2017.1321048","article-title":"Nanodispersion-loaded mucoadhesive polymeric inserts for prolonged treatment of post-operative ocular inflammation","volume":"34","author":"Morsi","year":"2017","journal-title":"J. Microencapsul."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114909_b0115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1081\/DDC-120016687","article-title":"Evaluation of mathematical models describing drug release from estradiol transdermal systems","volume":"29","author":"Costa","year":"2003","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2025.114909_b0120","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.msec.2017.04.030","article-title":"Colloidal properties and in vitro evaluation of Hydroxy ethyl cellulose coated iron oxide particles for targeted drug delivery","volume":"78","author":"Bekaro\u011flu","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"issue":"24","key":"10.1016\/j.ejpb.2025.114909_b0125","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1002\/smll.200901219","article-title":"Biofunctionalized, phosphonate\u2010grafted, ultrasmall iron oxide nanoparticles for combined targeted cancer therapy and multimodal imaging","volume":"5","author":"Das","year":"2009","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114909_b0130","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1080\/10717544.2019.1687613","article-title":"Enhancement of zaleplon oral bioavailability using optimized self-nano emulsifying drug delivery systems and its effect on sleep quality among a sample of psychiatric patients","volume":"26","author":"Khalifa","year":"2019","journal-title":"Drug Deliv."},{"issue":"6","key":"10.1016\/j.ejpb.2025.114909_b0135","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.nano.2011.04.011","article-title":"ZnO nanorod-induced apoptosis in human alveolar adenocarcinoma cells via p53, survivin and bax\/bcl-2 pathways: role of oxidative stress","volume":"7","author":"Ahamed","year":"2011","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114909_b0140","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12951-021-00851-2","article-title":"Synthesis and self-assembly of curcumin-modified amphiphilic polymeric micelles with antibacterial activity","volume":"19","author":"Barros","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejpb.2025.114909_b0145","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jddst.2019.03.039","article-title":"Docetaxel-loaded lipid-polymer hybrid nanoparticles for breast cancer therapeutics","volume":"51","author":"Jadon","year":"2019","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114909_b0150","first-page":"101","article-title":"Pluronic lecithin organogel for local delivery of anti-inflammatory drugs","volume":"8","author":"Franckum","year":"2004","journal-title":"Int. J. Pharm. Compd."},{"key":"10.1016\/j.ejpb.2025.114909_b0155","first-page":"180","article-title":"The history of pluronic lecithin organogel: an interview with Marty Jones","volume":"7","author":"Loyd","year":"2003","journal-title":"Int. J. Pharm. Compd."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114909_b0160","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/10717540903447194","article-title":"In situ gels of metoclopramide hydrochloride for intranasal delivery: in vitro evaluation and in vivo pharmacokinetic study in rabbits","volume":"17","author":"Mahajan","year":"2010","journal-title":"Drug Deliv."},{"issue":"9","key":"10.1016\/j.ejpb.2025.114909_b0165","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1080\/10717544.2016.1212439","article-title":"Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid","volume":"23","author":"Jhawat","year":"2016","journal-title":"Drug Deliv."},{"issue":"6","key":"10.1016\/j.ejpb.2025.114909_b0170","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3109\/10837450.2010.508074","article-title":"Rheological and mechanical properties of poloxamer mixtures as a mucoadhesive gel base","volume":"16","author":"Baloglu","year":"2011","journal-title":"Pharm. Dev. Technol."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2025.114909_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.01.045","article-title":"A thermo-and pH-sensitive hydrogel composed of quaternized chitosan\/glycerophosphate","volume":"315","author":"Wu","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114909_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2021.102504","article-title":"Lepidium sativum seed oil 3D nano-oleogel for the management of diabetic wounds: GC\/MS analysis, in-vitro and in-vivo studies","volume":"63","author":"Kamel","year":"2021","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2025.114909_b0185","first-page":"305","article-title":"A review on mucoadhesive buccal drug delivery system","volume":"7","author":"Aher","year":"2018","journal-title":"World J. Pharm. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114909_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-021-02020-y","article-title":"Intranasal in situ gel of apixaban-loaded nanoethosomes: preparation, optimization, and in vivo evaluation","volume":"22","author":"El-Shenawy","year":"2021","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.ejpb.2025.114909_b0195","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1208\/s12249-010-9540-7","article-title":"Preparation and evaluation of tubular micelles of pluronic lecithin organogel for transdermal delivery of sumatriptan","volume":"11","author":"Agrawal","year":"2010","journal-title":"AAPS PharmSciTech"},{"issue":"10","key":"10.1016\/j.ejpb.2025.114909_b0200","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.3390\/pharmaceutics13101640","article-title":"Nose to brain delivery of phenytoin sodium loaded nano lipid carriers: formulation, drug release, permeation and in vivo pharmacokinetic studies","volume":"13","author":"Nair","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114909_b0205","doi-asserted-by":"crossref","first-page":"E39","DOI":"10.1208\/pt070488","article-title":"Transdermal delivery of diclofenac sodium through rat skin from various formulations","volume":"7","author":"\u00d6zg\u00fcney","year":"2006","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"10.1016\/j.ejpb.2025.114909_b0210","first-page":"769","article-title":"Lyophilized chitosan\/xanthan polyelectrolyte complex based mucoadhesive inserts for nasal delivery of promethazine hydrochloride","volume":"13","author":"Dehghan","year":"2014","journal-title":"Iran. J. Pharm. Res."},{"issue":"11","key":"10.1016\/j.ejpb.2025.114909_b0215","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.lfs.2007.08.003","article-title":"Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice","volume":"81","author":"Peng","year":"2007","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114909_b0220","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0031-9384(90)90306-O","article-title":"A possible alarm substance in the forced swimming test","volume":"48","author":"Abel","year":"1990","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejpb.2025.114909_b0225","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.physbeh.2014.01.037","article-title":"Individual differences in the forced swimming test and neurochemical kinetics in the rat brain","volume":"128","author":"Sequeira-Cordero","year":"2014","journal-title":"Physiol. Behav."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2025.114909_b0230","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0166-4328(96)00067-8","article-title":"Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth","volume":"73","author":"Detke","year":"1995","journal-title":"Behav. Brain Res."},{"issue":"4\u20135","key":"10.1016\/j.ejpb.2025.114909_b0235","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","article-title":"Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejpb.2025.114909_b0240","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pbb.2017.12.006","article-title":"The antipsychotic trifluoperazine reduces marble-burying behavior in mice via D2 and 5-HT2A receptors: implications for obsessive\u2013compulsive disorder","volume":"165","author":"Egashira","year":"2018","journal-title":"Pharmacol. Biochem. Behav"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2025.114909_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2005.11.050","article-title":"Trifluoperazine, an orally available clinically used drug, disrupts opioid antinociceptive tolerance","volume":"397","author":"Tang","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"24","key":"10.1016\/j.ejpb.2025.114909_b0250","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1016\/j.biomaterials.2010.04.043","article-title":"Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration","volume":"31","author":"Chertok","year":"2010","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114909_b0255","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/MAO.0b013e318277a40e","article-title":"Magnetic targeted delivery of dexamethasone acetate across the round window membrane in guinea pigs","volume":"34","author":"Du","year":"2013","journal-title":"Otol. Neurotol."},{"issue":"5","key":"10.1016\/j.ejpb.2025.114909_b0260","first-page":"769","article-title":"Evaluation of antidepressant like activity of curcumin and its combination with fluoxetine and imipramine: an acute and chronic study","volume":"68","author":"Sanmukhani","year":"2011","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114909_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122838","article-title":"Repositioning of baricitinib for management of memory impairment in ovariectomized\/D-galactose treated rats: a potential role of JAK2\/STAT3-PI3K\/AKT\/mTOR signaling pathway","volume":"351","author":"Hindam","year":"2024","journal-title":"Life Sci."},{"issue":"1\u20133","key":"10.1016\/j.ejpb.2025.114909_b0270","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.colsurfa.2006.11.055","article-title":"Size control of poly (d, l-lactide-co-glycolide) and poly (d, l-lactide-co-glycolide)-magnetite nanoparticles synthesized by emulsion evaporation technique","volume":"299","author":"Astete","year":"2007","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2025.114909_b0275","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijpharm.2005.06.024","article-title":"Development and characterization of sub-micron poly (D, L-lactide-co-glycolide) particles loaded with magnetite\/maghemite nanoparticles","volume":"302","author":"Okassa","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.ejpb.2025.114909_b0280","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1039\/C0JM03232H","article-title":"Controlled loading of superparamagnetic nanoparticles in fluorescent nanogels as effective T 2-weighted MRI contrast agents","volume":"21","author":"Choo","year":"2011","journal-title":"J. Mater. Chem."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114909_b0285","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1021\/nn406349z","article-title":"Insertion of nanoparticle clusters into vesicle bilayers","volume":"8","author":"Bonnaud","year":"2014","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.ejpb.2025.114909_b0290","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1021\/acs.nanolett.6b02261","article-title":"Magnetic drug targeting: preclinical in vivo studies, mathematical modeling, and extrapolation to humans","volume":"16","author":"Al-Jamal","year":"2016","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejpb.2025.114909_b0295","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jcis.2015.11.071","article-title":"Controlled magnetosomes: Embedding of magnetic nanoparticles into membranes of monodisperse lipid vesicles","volume":"466","author":"Bixner","year":"2016","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2025.114909_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118447","article-title":"Coated nanostructured lipid carriers targeting the joints\u2013an effective and safe approach for the oral management of rheumatoid arthritis","volume":"567","author":"Zewail","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114909_b0305","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.taap.2010.03.011","article-title":"The inhibitory effect of superparamagnetic iron oxide nanoparticle (Ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells","volume":"245","author":"Chen","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejpb.2025.114909_b0310","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/ijms17081209","article-title":"Liposomes loaded with hydrophobic iron oxide nanoparticles: suitable T2 contrast agents for MRI","volume":"17","author":"Mart\u00ednez-Gonz\u00e1lez","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114909_b0315","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0168-3659(87)90035-6","article-title":"A simple equation for description of solute release II. Fickian and anomalous release from swellable devices","volume":"5","author":"Ritger","year":"1987","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ejpb.2025.114909_b0320","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.colsurfb.2009.05.031","article-title":"Effect of surface charge and agglomerate degree of magnetic iron oxide nanoparticles on KB cellular uptake in vitro","volume":"73","author":"Ge","year":"2009","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejpb.2025.114909_b0325","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.matlet.2016.12.010","article-title":"Saccharide-coated superparamagnetic Fe3O4 nanoparticles (SPIONs) for biomedical applications: an efficient and scalable route for preparation and in situ surface coating through cathodic electrochemical deposition (CED)","volume":"189","author":"Karimzadeh","year":"2017","journal-title":"Mater. Lett."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114909_b0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40199-015-0124-7","article-title":"The impact of polymer coatings on magnetite nanoparticles performance as MRI contrast agents: a comparative study","volume":"23","author":"Khalkhali","year":"2015","journal-title":"Daru J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114909_b0335","doi-asserted-by":"crossref","unstructured":"A. Post, R.J. Warren, and J.E. Zarembo, Trifluoperazine hydrochloride, in Analytical profiles of drug substances. 1981, Elsevier. p. 543-581.","DOI":"10.1016\/S0099-5428(08)60153-7"},{"key":"10.1016\/j.ejpb.2025.114909_b0340","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2147\/DDDT.S43035","article-title":"Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system","volume":"7","author":"Dorniani","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114909_b0345","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1208\/s12248-015-9837-2","article-title":"Preparation and evaluation of phospholipid-based complex of standardized centella extract (SCE) for the enhanced delivery of phytoconstituents","volume":"18","author":"Saoji","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2025.114909_b0350","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.colsurfa.2007.04.078","article-title":"Poly (d, l-lactide-co-glycolide) coated superparamagnetic iron oxide nanoparticles: synthesis, characterization and in vivo study as MRI contrast agent","volume":"313","author":"Patel","year":"2008","journal-title":"Colloids Surf., A Physicochem. Eng. Asp"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2025.114909_b0355","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2005.01.042","article-title":"Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate","volume":"295","author":"Wu","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114909_b0360","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/030089160509100402","article-title":"Concurrent 5-fluorouracil, mitomycin C and radiation with or without brachytherapy in recurrent cervical cancer: a scoring system to predict clinical response and outcome","volume":"91","author":"Smaniotto","year":"2005","journal-title":"Tumori J."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114909_b0365","first-page":"1","article-title":"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings","volume":"8","author":"Feng","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114909_b0370","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5530\/pj.2020.12.3","article-title":"In vitro cytotoxicity of Hibiscus sabdariffa Linn extracts on A549 lung cancer cell line","volume":"12","author":"Fithrotunnisa","year":"2020","journal-title":"Pharmacognosy J."},{"issue":"9","key":"10.1016\/j.ejpb.2025.114909_b0375","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1517\/17425247.2013.796360","article-title":"Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview","volume":"10","author":"Almeida","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114909_b0380","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/10717540903508961","article-title":"Pluronic lecithin organogel as a topical drug delivery system","volume":"17","author":"Pandey","year":"2010","journal-title":"Drug Deliv."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114909_b0385","first-page":"577","article-title":"In-situ gel nasal drug delivery system-a review","volume":"4","author":"Vibha","year":"2014","journal-title":"Int. J. Pharma Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114909_b0390","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/03639045.2016.1225754","article-title":"Thermoreversible mucoadhesive in situ nasal gel for treatment of Parkinson\u2019s disease","volume":"43","author":"Rao","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114909_b0395","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/03639045.2016.1254239","article-title":"Thermosensitive bioadhesive gels for the vaginal delivery of sildenafil citrate: in vitro characterization and clinical evaluation in women using clomiphene citrate for induction of ovulation","volume":"43","author":"Soliman","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2025.114909_b0400","first-page":"24","article-title":"In-situ gelling system: a novel approach for ocular drug delivery","volume":"2","author":"Rajoria","year":"2012","journal-title":"Am. J. Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114909_b0405","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejpb.2015.05.017","article-title":"Thermoresponsive hydrogels in biomedical applications: a seven-year update","volume":"97","author":"Klouda","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114909_b0410","unstructured":"M. Paulsson, Controlled release gel formulations for mucosal drug delivery. 2001, Acta Universitatis Upsaliensis. p. 9-21."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2025.114909_b0415","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejps.2012.10.029","article-title":"Ex vivo permeation characteristics of venlafaxine through sheep nasal mucosa","volume":"48","author":"Pund","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114909_b0420","doi-asserted-by":"crossref","first-page":"294","DOI":"10.25004\/IJPSDR.2010.020415","article-title":"Preparation and evaluation of intraoral drug delivery system for rasagiline mesylate","volume":"2","author":"Bukka","year":"2010","journal-title":"Int. J. Pharm. Sci. Drug Res."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114909_b0425","first-page":"185","article-title":"Mucoadhesive and drug release properties of benzocaine gel","volume":"2","author":"Jelvehgari","year":"2006","journal-title":"Iran. J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.ejpb.2025.114909_b0430","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3109\/10717544.2010.483255","article-title":"New method for ophthalmic delivery of azithromycin by poloxamer\/carbopol-based in situ gelling system","volume":"17","author":"Cao","year":"2010","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2025.114909_b0435","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0927-7757(01)00511-8","article-title":"Lecithin organogel: a micellar system with unique properties","volume":"183","author":"Shchipunov","year":"2001","journal-title":"Colloids Surf., A Physicochem. Eng. Asp"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114909_b0440","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5173(02)00234-X","article-title":"In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate","volume":"241","author":"El-Kamel","year":"2002","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114909_b0445","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/pharmaceutics10040197","article-title":"Formulation and characterization of carvedilol leciplex for glaucoma treatment: in-vitro, ex-vivo and in-vivo study","volume":"10","author":"Hassan","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114909_b0450","doi-asserted-by":"crossref","unstructured":"A.A. Date and V.B. Patravale, Microemulsions: applications in transdermal and dermal delivery. Critical reviews\u2122 in therapeutic drug carrier systems, 2007. 24(6): p. 547-596.","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v24.i6.20"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114909_b0455","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/0250-474X.51955","article-title":"Topical delivery of flurbiprofen from pluronic lecithin organogel","volume":"71","author":"Pandey","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114909_b0460","doi-asserted-by":"crossref","first-page":"592","DOI":"10.18433\/J3HW2B","article-title":"Pluronic\u00ae F-127 and Pluronic Lecithin Organogel (PLO): main features and their applications in topical and transdermal administration of drugs","volume":"15","author":"Almeida","year":"2012","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ejpb.2025.114909_b0465","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/10837450701247400","article-title":"Preparation, rheological study, and characterization of an organogel as a system for transdermal release of active principles","volume":"12","author":"Ruiz","year":"2007","journal-title":"Pharm. Dev. Technol."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114909_b0470","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1023\/B:PHAR.0000026823.82950.ff","article-title":"Nasal route and drug delivery systems","volume":"26","author":"T\u00fcrker","year":"2004","journal-title":"Pharm. World Sci."},{"key":"10.1016\/j.ejpb.2025.114909_b0475","article-title":"Engineering of structural and functional properties of nanotherapeutics and nanodiagnostics for intranasal brain targeting in Alzheimer's","volume":"26","author":"Hinge","year":"2022","journal-title":"Appl. Mater. Today"},{"issue":"12","key":"10.1016\/j.ejpb.2025.114909_b0480","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1007\/s11095-015-1744-9","article-title":"Intranasal H102 peptide-loaded liposomes for brain delivery to treat Alzheimer\u2019s disease","volume":"32","author":"Zheng","year":"2015","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114909_b0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-3155-4-4","article-title":"The permeability of SPION over an artificial three-layer membrane is enhanced by external magnetic field","volume":"4","author":"Mondalek","year":"2006","journal-title":"J. Nanobiotechnol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125002863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125002863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T22:01:45Z","timestamp":1769810505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125002863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":97,"alternative-id":["S0939641125002863"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114909","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of intranasal trifluoperazine\/SPION-leciplex thermosensitive organogel for depression therapy: Pharmacodynamic and pharmacokinetic comparison of magnet placement effects on brain versus nose","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114909","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114909"}}